April 27, 2021
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
| Re: | Notice of disclosure filed in Annual Report on Form 20-F pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended |
Ladies and Gentlemen:
Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended, notice is hereby provided that Capital Product Partners L.P. has made disclosure pursuant to those provisions in its Annual Report on Form 20-F for the year ended December 31, 2020, which was filed with the U.S. Securities and Exchange Commission on April 27, 2021.
Respectfully submitted,
| CAPITAL PRODUCT PARTNERS L.P.
| ||
| By: |
Capital GP L.L.C., its general partner
| |
| By: |
/s/ Gerasimos (Jerry) Kalogiratos | |
| Name: |
Gerasimos (Jerry) Kalogiratos | |
| Title: |
Chief Executive Officer of Capital GP L.L.C. | |